Skip to Main Content
CWRU Links

GvHD 2017

GvHD Banner

Program Overview

This unique conference, which focuses on cutting edge research and new treatments, consists of two tracks: one designed for physicians and other health care professionals, and one for bone marrow transplant (BMT) survivors, their families and their caregivers. The Meredith A. Cowden Foundation in collaboration with the Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, and Cleveland Clinic Taussig Cancer Institute, created the National GvHD Health Symposium in 2010 to raise awareness about Graft vs. Host Disease (GvHD), to promote research to further our understanding of its cause, and to review cutting edge approaches to prevention and treatment. Over 1,200 people have attended this event, which provides an opportunity for attendees to interact with some of the world's leading authorities on GvHD, a complication that affects over 60% of bone marrow transplant patients. This year we are excited to team up with the The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, who will serve as hosts of the 2017 symposium!

At the conclusion of this conference, participants will be prepared to:

  1. Discuss current advances in the biology and treatment of acute GvHD              
  2. Describe novel targets and new agents in the treatment of chronic GvHD
  3. Illustrate how biomarkers are being used for the treatment of acute GvHD
  4. Discuss the role of the microbiome in the pathogenesis of chronic GvHD
  5. Identify the genital and ocular complications of chronic GvHD and current treatment strategies
  6. Define the causes of opportunistic infection that can occur in patients with chronic GvHD

Agenda

Friday, October 13, 2017

7:30-8:00 am 

Registration/Continental Breakfast/Sponsor Display Tables

8:00-8:15

Welcome
Gerry Cowden, Founder; Matt Kalaycio, MD; Steven Devine, MD; Kenneth Cooke, MD; Marcos de Lima, MD; Steve Pavletic, MD, MS

8:15-8:25

Transition (physician track participants to different location)

8:25-9:05

SESSION 1

 

PHYSICIANS
Survivorship and the 2016 NIH Late Effects Consensus Initiative
Navneet Majhail, MD

PATIENTS / FAMILIES
GvHD 101 / Steroids and cGvHD
Hien Liu, MDSamantha Jaglowski, MD

 

9:10-9:50

SESSION 2

 

PHYSICIANS
New Drugs for cGvHD
Paul Martin, MD

PATIENTS / FAMILIES
Sexuality
Karen Syrjala, PhD

9:50-10:05

Break 

10:05-10:45

SESSION 3

 

PHYSICIANS
Genital GvHD
Pamela Stratton, MD

PATIENTS / FAMILIES
Oral GvHD
Nathaniel Treister, DMD, DMSc

10:50-11:30

SESSION 4

 

PHYSICIANS
Microbiome and GvHD
Robert Jenq, MD

PATIENTS / FAMILIES
Nutritional Issues
Lindsay Malone, MS, RD, LD

11:30-11:45

Break and Information/Sponsor Exhibit Tables 

12:00-12:30

Luncheon is served

12:30-1:15

KEYNOTE PRESENTATION

Biomarkers in Graft versus Host Disease: Acute and Chronic
James Ferrara, MD

1:15-2:00

Panel Discussion 

2:00-2:15

Break and transition to afternoon session rooms

2:15-2:55

SESSION 5

 

PHYSICIANS
Opportunistic Infections in the
Immune-Compromised Host
Jeffery Auletta, MD

PATIENTS /  FAMILIES
Lung Problems
Karen Wood, MD
Kenneth Cooke, MD

2:55-3:05

Break

3:05-3:45

SESSION 6

 

PHYSICIANS
Translational and Clinical Research in Chronic Ocular GvHD
Sandeep Jain, MD

 

PATIENTS / FAMILIES
Meet the Experts

3:45-4:00

Break/Return to General Session 

4:00-4:15

Closing Comments 

4:15-5:30

Cocktail Reception